How do sickle cell disease clinic nurses explain hydroxyurea to Spanish-speaking patients who believe it is a chemotherapy drug?

The most common reason Spanish-speaking patients with sickle cell disease stop hydroxyurea is the belief, often received from a family member or friend who has taken hydroxyurea for cancer, that the medication is a chemotherapy drug that causes hair loss, immune suppression, and organ damage. The sickle cell clinic nurse needs to explain the distinction at the level of mechanism and dose, not just at the level of labels. Hydroxyurea was developed and has been used for decades to treat certain cancers, including leukemia and polycythemia vera, at doses substantially higher than those used in sickle cell disease. In those cancer applications, hydroxyurea works by blocking DNA synthesis to stop rapidly dividing cells. In sickle cell disease, the dose is lower and the therapeutic mechanism is different: hydroxyurea stimulates the production of fetal hemoglobin (HbF), a form of hemoglobin that is normally present in high amounts in newborns but is largely replaced by adult hemoglobin (HbA or HbS) after birth. In patients with sickle cell disease (HbSS), fetal hemoglobin dilutes the HbS in red blood cells and physically prevents the HbS polymerization that causes sickling. The higher the proportion of HbF in any given red blood cell, the less likely that cell is to sickle under low oxygen conditions. A patient who stops hydroxyurea loses the HbF-elevating effect over weeks to months as the drug clears and HbF production returns to baseline, which is why crises that were suppressed for years can return rapidly after discontinuation. “La hidroxiurea se usó primero para tratar cáncer, y por eso su amiga la conocía. Pero la forma en que funciona para la enfermedad de células falciformes es completamente diferente. En cáncer se usa a dosis mucho más altas para detener células que están creciendo de forma anormal. En su enfermedad, la dosis es mucho más baja y el objetivo es diferente: hacer que su cuerpo produzca más hemoglobina fetal, que es el tipo de hemoglobina que tienen los bebés. Esa hemoglobina fetal se mezcla con la hemoglobina falciforme y evita que los glóbulos rojos se deformen y bloqueen los vasos. Cuando usted dejó de tomarla, ese mecanismo de protección desapareció, y por eso tuvieron dos crisis en seis semanas después de dos años sin ninguna.” (Hydroxyurea was first used to treat cancer, and that is why your friend knew it. But the way it works for sickle cell disease is completely different. In cancer it is used at much higher doses to stop cells that are growing abnormally. In your disease, the dose is much lower and the goal is different: to make your body produce more fetal hemoglobin, which is the type of hemoglobin that babies have. That fetal hemoglobin mixes with the sickle hemoglobin and prevents the red blood cells from deforming and blocking the vessels. When you stopped taking it, that protection mechanism disappeared, and that is why you had two crises in six weeks after two years without any.)

How do sickle cell disease clinic nurses explain silent stroke to Spanish-speaking patients and families?

Silent cerebral infarcts are one of the most serious complications of sickle cell disease and among the hardest to explain because they produce no acute symptoms the patient can recognize. Unlike an overt stroke with sudden weakness or speech loss, silent infarcts accumulate quietly in the white matter of the brain over years, producing cognitive changes, memory difficulties, and school or work performance problems that the patient and family attribute to fatigue, stress, or other causes. The sickle cell clinic nurse explaining silent stroke to a Spanish-speaking patient needs to explain three things. First, what happened and where: the MRI shows areas of the brain where small blood vessels were blocked by sickle cells long enough to cause tissue damage, even though the patient did not feel a classic stroke at the time. Second, why they matter: each silent infarct represents permanent tissue loss that does not reverse, and the cumulative effect over years is measurable cognitive impairment; patients who have had one or more silent infarcts are also at elevated risk for future overt stroke. Third, what can be done now: for patients with silent infarcts and elevated transcranial Doppler velocities indicating elevated cerebral blood flow velocity (a marker for high stroke risk), chronic transfusion therapy reduces the proportion of HbS in circulation by regularly replacing sickle cells with donor red cells, reducing the risk of future stroke by approximately 90% in clinical trials. “El MRI muestra áreas en el cerebro donde los vasos pequeños estuvieron bloqueados por glóbulos rojos falciformes en algún momento. No produce los síntomas clásicos de un derrame — no hay debilidad súbita, no hay pérdida del habla — pero el tejido sí sufre daño permanente. Por eso se llama infarto cerebral silencioso: no se siente en el momento, pero sí queda. El tratamiento que tenemos más evidencia para reducir el riesgo de que esto siga pasando es la transfusión crónica, que reemplaza regularmente sus glóbulos rojos con glóbulos de un donante para que la proporción de hemoglobina falciforme en la sangre baje a un nivel donde el riesgo de bloquear los vasos del cerebro sea mucho menor.” (The MRI shows areas of the brain where small blood vessels were blocked by sickle red blood cells at some point. It does not produce the classic symptoms of a stroke — no sudden weakness, no loss of speech — but the tissue does suffer permanent damage. That is why it is called a silent cerebral infarct: it is not felt at the moment, but it does remain. The treatment with the strongest evidence to reduce the risk of this continuing to happen is chronic transfusion, which regularly replaces your red blood cells with red blood cells from a donor so that the proportion of sickle hemoglobin in the blood drops to a level where the risk of blocking the brain vessels is much lower.)

How do sickle cell disease clinic nurses help Spanish-speaking patients navigate the emergency department during a vaso-occlusive crisis?

One of the most documented and harmful barriers to sickle cell crisis care in the United States is the clinical encounter with a triage nurse or emergency physician who treats the patient as a drug-seeker rather than as a patient in severe acute pain. The consequence — patients avoiding the ED and managing severe crises at home — leads directly to untreated severe pain, tissue hypoxia, organ damage, and the silent strokes and complications that follow months of inadequately treated sickling. The sickle cell clinic nurse has a specific role to play in preventing this outcome: preparing the patient to advocate effectively at triage before the crisis prevents articulate communication. This preparation includes three elements. First, the name of the diagnosis: “Tengo enfermedad de células falciformes, tipo HbSS. Estoy teniendo una crisis vaso-oclusiva.” (I have sickle cell disease, type HbSS. I am having a vaso-occlusive crisis.) Second, the name of the protocol that should be activated: many hospitals with sickle cell programs have a pain protocol that specifies rapid administration of opioid analgesia within 30 to 60 minutes of triage. The patient should know whether their hospital has such a protocol and be able to say: “¿El hospital tiene un protocolo para crisis de células falciformes? Mi hematología tiene una carta con mi plan de manejo.” (Does the hospital have a sickle cell crisis protocol? My hematology team has a letter with my management plan.) Third, when to go: a crisis that reaches 6 out of 10 on the pain scale, is not responding to home oral analgesia within two hours, is accompanied by fever, chest pain, or shortness of breath, or is in a patient who has had any stroke or silent stroke on prior imaging should prompt ED evaluation rather than home management — the risk of delayed treatment in these situations outweighs the risk of the ED encounter.

How do sickle cell disease clinic nurses explain sickle cell leg ulcers to Spanish-speaking patients who believe their wounds are infected?

Sickle cell leg ulcers are caused by a fundamentally different mechanism than infected wounds or diabetic ulcers, and the treatment accordingly differs. The sickle cell clinic nurse working with a Spanish-speaking patient who has been treating her leg ulcers as infected wounds needs to explain this distinction without invalidating the patient’s logic: the ulcers look like infected wounds (they are open, they may be draining, they may be surrounded by inflamed tissue), and treating an infected-looking wound with an antibacterial ointment is a reasonable thing to do if no one has explained why the wound is not healing. Sickle cell leg ulcers form preferentially on the medial and lateral malleoli — the bony prominences of the ankle — because the skin over these areas is thin, the subcutaneous tissue is sparse, the local blood supply is marginal, and venous drainage is relatively slow. In a patient with HbSS disease, the sickle cells that circulate through these small vessels periodically polymerize and block local blood flow, creating microinfarcts of the skin and subcutaneous tissue. The wound that forms is not primarily infected — it is ischemic. Secondary infection can occur at the wound surface, but the fundamental problem preventing healing is not bacteria. It is the chronic, intermittent reduction of blood supply to a tissue that depends on blood supply to heal. Neosporin addresses bacteria at the wound surface; it does not reach the small vessel ischemia that is preventing granulation tissue from forming, wound edges from contracting, and new skin from growing. Specialized wound care — debridement to remove non-viable tissue, moisture-retentive dressings, compression if venous insufficiency is a co-factor, zinc supplementation, and in some patients hydroxyurea or transfusion to reduce sickling in the wound bed — addresses the underlying pathology in ways that over-the-counter antibacterial ointment cannot. “Las heridas que tiene en los tobillos no son infecciones. Son heridas que se forman porque los glóbulos rojos falciformes bloquean los vasos pequeños de la piel en esa área, y sin flujo de sangre normal, la piel no tiene los materiales que necesita para sanar. La Neosporina puede prevenir que bacterias entren en la superficie, pero no llega al problema de fondo, que es que el tejido necesita más sangre de la que está recibiendo para cerrarse. La clínica de cuidado de heridas tiene apósitos especializados y tratamientos que crean las condiciones que el tejido necesita para cicatrizar a pesar del flujo limitado.” (The wounds you have on your ankles are not infections. They are wounds that form because sickle red blood cells block the small vessels of the skin in that area, and without normal blood flow, the skin does not have the materials it needs to heal. Neosporin may prevent bacteria from entering at the surface, but it does not reach the underlying problem, which is that the tissue needs more blood than it is receiving to close. The wound care clinic has specialized dressings and treatments that create the conditions the tissue needs to heal despite the limited blood flow.)

What are the most important Spanish phrases for sickle cell disease clinic nurses?

Sickle cell disease clinic nursing involves three recurring communication failures with Spanish-speaking patients. The first is the patient who has stopped or never started hydroxyurea because of misinformation about chemotherapy, addiction, or side effects. The second is the patient who is managing crises at home because of a prior bad experience in the ED, accumulating end-organ damage with every inadequately treated sickling event. The third is the patient whose sickle cell complications — leg ulcers, acute chest syndrome, silent stroke, avascular necrosis — have been framed as infection, pneumonia, fatigue, or arthritis because no one has explained the connection to the underlying disease. For hydroxyurea adherence: “la hidroxiurea en la enfermedad de células falciformes no funciona como quimioterapia — funciona haciendo que su cuerpo produzca hemoglobina fetal, que se mezcla con la hemoglobina falciforme y reduce la proporción de glóbulos que se pueden deformar; cuando la dejó de tomar, esa protección desapareció.” For crisis and ED navigation: “cuando el dolor llega a seis de diez y los medicamentos de la casa no lo controlan en dos horas, eso es el momento de ir a urgencias — no después de cuatro horas en la cama; en la sala de emergencias, diga: tengo enfermedad de células falciformes, tipo HbSS, estoy teniendo una crisis vaso-oclusiva, y pregunte si tienen un protocolo para esto.” For sickle cell leg ulcers: “estas heridas se forman por falta de flujo sanguíneo, no por infección; la Neosporina no llega al problema de fondo; el cuidado especializado de heridas tarda meses en funcionar pero es el único camino para cerrarlas.” For silent stroke: “el MRI muestra áreas donde los vasos del cerebro estuvieron bloqueados; no hubo síntomas en el momento pero el daño sí quedó; la transfusión crónica reduce el riesgo de que esto siga pasando en un noventa por ciento.” (For hydroxyurea adherence: “hydroxyurea in sickle cell disease does not work like chemotherapy — it works by making your body produce fetal hemoglobin, which mixes with the sickle hemoglobin and reduces the proportion of cells that can deform; when you stopped taking it, that protection disappeared.” For crisis and ED navigation: “when the pain reaches six out of ten and the home medications do not control it within two hours, that is the moment to go to the emergency department — not after four hours in bed; in the emergency room, say: I have sickle cell disease, type HbSS, I am having a vaso-occlusive crisis, and ask if they have a protocol for this.” For sickle cell leg ulcers: “these wounds form from lack of blood flow, not from infection; Neosporin does not reach the underlying problem; specialized wound care takes months to work but it is the only path to closing them.” For silent stroke: “the MRI shows areas where the brain vessels were blocked; there were no symptoms at the time but the damage did remain; chronic transfusion reduces the risk of this continuing to happen by ninety percent.”)

July 23, 2026 · Clinical Spanish · Sickle Cell Disease · Hematology Nursing · Chronic Disease Management

Spanish for sickle cell disease clinic nurses — the patient who stopped hydroxyurea because a friend told her it was chemotherapy, the patient who has been managing vaso-occlusive crises at home for eight months and now has two silent strokes on MRI, and the patient whose sickle cell leg ulcers she has been treating with Neosporin for three months

Daniela Cruz is 28. She is a hotel housekeeper from Phoenix with HbSS sickle cell disease, the most severe genotype. She has been followed in the hematology clinic since she was nine years old. For the two years before last November, her disease was quiet. She had not had a vaso-occlusive crisis requiring an emergency department visit in twenty-six months. She was on hydroxyurea 1,000 mg daily, her fetal hemoglobin was 18%, and her clinic nurse describes her, in her chart notes, as one of the most adherent patients in the panel.

Last November, her closest friend — a woman who has been treated for chronic myelogenous leukemia for three years — saw Daniela’s hydroxyurea prescription bottle and told her something that has not left Daniela’s mind since.

— Daniela, yo tomé exactamente eso. Es quimioterapia. Me cayó muy mal. Se me cayó el pelo, se me bajaron los glóbulos blancos, tuve infecciones. Eso no te lo puede estar dando el médico para la anemia. Hay algo que no te están diciendo.

Daniela, I took exactly that. It is chemotherapy. It hit me very hard. My hair fell out, my white blood cells dropped, I got infections. They cannot be giving you that for anemia. There is something they are not telling you.

Daniela stopped the hydroxyurea the next day. She did not call the clinic. She did not tell anyone. She believed her friend, who had lived the experience firsthand, over the pharmacist who had dispensed it and the hematologist who had prescribed it for nineteen years.

Six weeks ago, she had a severe vaso-occlusive crisis — her first in over two years. She went to the emergency department, was given intravenous morphine, and was discharged after eight hours. Three weeks later, she had a second crisis, equally severe. She is now in the sickle cell clinic, four months after stopping the hydroxyurea, for a scheduled follow-up visit. Her fetal hemoglobin on today’s labs is 6%.

— No entiendo por qué de repente estoy tan mal si hace tres años no tenía ninguna crisis.

I do not understand why I am suddenly so bad when three years ago I had no crises at all.

What this post covers

This post covers three conversations that recur in sickle cell disease clinic nursing when the patient speaks Spanish. The first is Daniela’s — the patient who stopped a medication that was controlling her disease because a trusted person in her life, speaking from genuine personal experience, told her something that was true in one context and false in hers. The second is Marcos Reyes, 19, a construction apprentice from Houston with HbSS disease who stopped coming to the ED when he had vaso-occlusive crises after an experience in which he waited four hours at the triage desk, in severe pain, while the nursing staff’s body language and comments made clear they believed he was seeking opioids. He has been managing crises at home for eight months with heat, extra ibuprofen, and rest. He is in clinic today because his annual MRI shows two new silent cerebral infarcts and his transcranial Doppler velocity is borderline elevated. The third is Elena Fuentes, 34, a daycare worker from Chicago with HbSS disease who has had open wounds on both medial ankle bones for three months. She has been treating them with Neosporin and cloth bandages every night. She has not come to wound care because a neighbor told her that leg wounds in people with diabetes are different from her wounds, and she does not have diabetes, so the wounds must be something else and will heal on their own.

In each case the patient is making a decision that is internally coherent given what she knows. In each case the clinic nurse who names the mechanism plainly, explains the connection between the decision and the harm that followed, and offers a path forward in Spanish is the person who closes the gap before it produces the next crisis, the next infarct, or the next three months of non-healing wounds.

Scenario one: Daniela and the hydroxyurea she stopped

The clinic nurse, Alejandra Vega, has been in the sickle cell clinic for eleven years. She has heard many versions of the hydroxyurea-as-chemotherapy conversation. She knows that the most important thing she can do before explaining why the medication is not what Daniela’s friend described is to validate why Daniela believed her friend. The friend was not lying. The friend was telling the truth about her own experience. The error was not deception. It was a category mistake that no one corrected before it caused harm.

Alejandra: — Daniela, antes de que veamos las pruebas de hoy, quiero hablar sobre la hidroxiurea, porque veo que no la ha tomado en cuatro meses y quiero entender qué pasó.

Daniela, before we look at today’s results, I want to talk about the hydroxyurea, because I see you have not taken it in four months and I want to understand what happened.

Daniela explains about her friend. She is braced for a correction, or for the nurse to dismiss what her friend said.

Alejandra: — Lo que le dijo su amiga sobre la hidroxiurea era verdad para ella. Eso es lo primero que quiero que sepa. La hidroxiurea sí se usa para tratar ciertos tipos de leucemia, incluyendo el tipo que tiene su amiga. Y a las dosis que se usa para el cáncer, puede causar exactamente lo que ella describió: caída de cabello, disminución de los glóbulos blancos, infecciones. Lo que ella le dijo no fue un error. Fue su experiencia real.

What your friend told you about hydroxyurea was true for her. That is the first thing I want you to know. Hydroxyurea is indeed used to treat certain types of leukemia, including the type your friend has. And at the doses used for cancer, it can cause exactly what she described: hair loss, decrease in white blood cells, infections. What she told you was not a mistake. It was her real experience.

Daniela looks up. This is not what she expected.

Alejandra: — La diferencia está en el motivo y en la dosis. Para el cáncer, la hidroxiurea se usa a dosis muy altas para detener células que están creciendo de forma anormal y rápidamente. Ese es el mecanismo para el cáncer — y a esa dosis, los efectos secundarios que tuvo su amiga tienen sentido. Para la enfermedad de células falciformes, la dosis es mucho más baja y el objetivo es completamente diferente. No estamos tratando de detener células. Estamos tratando de hacer que su médula ósea produzca un tipo específico de hemoglobina que normalmente se produce en los bebés y que casi desaparece después del primer año de vida.

The difference is in the reason and the dose. For cancer, hydroxyurea is used at very high doses to stop cells that are growing abnormally and rapidly. That is the mechanism for cancer — and at that dose, the side effects your friend had make sense. For sickle cell disease, the dose is much lower and the goal is completely different. We are not trying to stop cells. We are trying to make your bone marrow produce a specific type of hemoglobin that is normally produced in babies and that almost disappears after the first year of life.

Daniela: — ¿Hemoglobina de bebé?

Baby hemoglobin?

Why fetal hemoglobin matters in sickle cell disease

Alejandra: — Exactamente. La hemoglobina fetal — la hemoglobina F — es la hemoglobina que todos tenemos antes de nacer y durante los primeros meses de vida. Es una hemoglobina que funciona muy bien para cargar oxígeno, pero más importante para usted: no forma los polímeros que forma la hemoglobina S. La hemoglobina falciforme, la HbS, tiene un defecto en su estructura que hace que cuando el glóbulo rojo pierde oxígeno, las moléculas de HbS se encadenen entre sí y formen estructuras rígidas que deforman el glóbulo rojo, lo convierten en la forma de media luna que da el nombre a la enfermedad, y bloquean los vasos pequeños. La hemoglobina fetal no hace esto. No puede unirse a la cadena de polímeros de HbS de la misma manera. Así que cuando la HbF está presente en un glóbulo rojo junto con la HbS, ese glóbulo rojo es mucho menos probable que se deforme y bloquee un vaso, porque la HbF está “diluyendo” la HbS y rompiendo las cadenas.

Exactly. Fetal hemoglobin — hemoglobin F — is the hemoglobin we all have before birth and during the first months of life. It is a hemoglobin that works very well for carrying oxygen, but more importantly for you: it does not form the polymers that hemoglobin S forms. Sickle hemoglobin, HbS, has a defect in its structure that causes the HbS molecules to chain together and form rigid structures when the red blood cell loses oxygen. Those rigid structures deform the red blood cell into the crescent shape that gives the disease its name, and they block the small vessels. Fetal hemoglobin does not do this. It cannot join the HbS polymer chain in the same way. So when HbF is present in a red blood cell alongside HbS, that red blood cell is much less likely to deform and block a vessel, because the HbF is “diluting” the HbS and breaking up the chains.

Daniela: — ¿Y la hidroxiurea hace que el cuerpo produzca más de esa hemoglobina fetal?

And hydroxyurea makes the body produce more of that fetal hemoglobin?

Alejandra: — Exactamente. La hidroxiurea actúa en la médula ósea de una manera que todavía los investigadores no entienden completamente al cien por ciento, pero el efecto es claro: aumenta la producción de hemoglobina fetal. Cuando usted estaba tomando la hidroxiurea y su hemoglobina fetal estaba en 18%, eso significa que aproximadamente 18 de cada 100 moléculas de hemoglobina en sus glóbulos rojos eran hemoglobina F — hemoglobina que no puede sicklificar. Eso fue suficiente para mantener sus glóbulos rojos lo suficientemente flexibles como para no bloquear los vasos en veintiséis meses. Hoy, cuatro meses después de que dejó de tomarla, su hemoglobina fetal es 6%. La protección se fue con el medicamento.

Exactly. Hydroxyurea acts on the bone marrow in a way that researchers still do not completely understand, but the effect is clear: it increases the production of fetal hemoglobin. When you were taking the hydroxyurea and your fetal hemoglobin was at 18%, that means approximately 18 out of every 100 hemoglobin molecules in your red blood cells were hemoglobin F — hemoglobin that cannot sickle. That was enough to keep your red blood cells flexible enough not to block the vessels for twenty-six months. Today, four months after you stopped taking it, your fetal hemoglobin is 6%. The protection left with the medication.

Daniela: — Por eso tuve las dos crisis.

That is why I had the two crises.

Alejandra: — Eso es lo que los laboratorios de hoy nos dicen, sí. Las dos crisis en seis semanas después de dos años sin ninguna — esa no es una coincidencia. Es la enfermedad volviendo al nivel de actividad que tenía antes de que la hidroxiurea la suprimiera.

That is what today’s labs are telling us, yes. Two crises in six weeks after two years with none — that is not a coincidence. It is the disease returning to the level of activity it had before hydroxyurea suppressed it.

What happens now and what Daniela should watch for

Alejandra: — Lo que voy a hacer hoy es reiniciar la hidroxiurea a la misma dosis que estaba tomando antes. Va a tardar unas semanas en volver a elevar su hemoglobina fetal, y va a tardar dos o tres meses hasta que llegue al nivel donde estaba. En ese tiempo, su riesgo de crisis sigue siendo más alto de lo que era cuando la estaba tomando. Entonces quiero que sepa cuándo llamarnos y cuándo ir a urgencias, porque no quiero que siga manejando las crisis en casa.

What I am going to do today is restart the hydroxyurea at the same dose you were taking before. It will take a few weeks to start elevating your fetal hemoglobin again, and it will take two to three months to reach the level it was at. During that time, your risk of crisis remains higher than it was when you were taking it. So I want you to know when to call us and when to go to the emergency department, because I do not want you to continue managing crises at home.

Daniela: — ¿Me va a caer igual que a mi amiga? ¿El pelo, las infecciones?

Is it going to hit me the same as my friend? The hair, the infections?

Alejandra: — A la dosis que le damos a usted, los efectos secundarios son diferentes. Las personas con enfermedad de células falciformes a veces tienen una disminución temporal en los glóbulos blancos y en las plaquetas — por eso le sacamos sangre cada tres meses mientras está en el medicamento, para asegurarnos de que los niveles estén bien. Si vemos que los números bajan demasiado, reducimos la dosis o pausamos el medicamento temporalmente hasta que suban. Lo que no solemos ver a estas dosis es la caída de cabello severa o las infecciones graves que su amiga describió. El perfil de efectos secundarios a dosis de enfermedad de células falciformes es significativamente diferente al perfil a dosis de cáncer.

At the dose we give you, the side effects are different. People with sickle cell disease sometimes have a temporary decrease in white blood cells and platelets — that is why we draw your blood every three months while you are on the medication, to make sure the levels are where they should be. If we see the numbers drop too low, we reduce the dose or pause the medication temporarily until they come back up. What we do not usually see at these doses is the severe hair loss or the serious infections your friend described. The side effect profile at sickle cell disease doses is significantly different from the profile at cancer doses.

Daniela: — Nadie me lo había explicado así. Que era lo mismo pero no era lo mismo.

Nobody had explained it to me like that. That it was the same but it was not the same.

Alejandra: — Lo entiendo. Si alguien que conoce bien y en quien usted confía le dice algo sobre un medicamento que está tomando, usted va a creerle — especialmente si esa persona lo vivió. Por eso quería empezar explicando que lo que le dijo su amiga fue verdadero para ella. Lo que necesito que sepa es que en su caso, el medicamento está haciendo algo diferente, a una dosis diferente, con un objetivo diferente. Y lo que vimos durante los dos años en que lo estaba tomando — cero crisis, hemoglobina fetal en 18% — eso también fue verdad.

I understand. If someone you know well and trust tells you something about a medication you are taking, you are going to believe them — especially if that person lived it. That is why I wanted to start by explaining that what your friend told you was true for her. What I need you to know is that in your case, the medication is doing something different, at a different dose, with a different goal. And what we saw during the two years you were taking it — zero crises, fetal hemoglobin at 18% — that was also true.

Daniela: — Está bien. Voy a volver a tomarla.

All right. I am going to take it again.

Scenario two: Marcos and the strokes that happened while he managed at home

Marcos Reyes is 19. He has HbSS sickle cell disease, diagnosed at birth through newborn screening. He grew up in Houston, the youngest of four brothers, the only one with sickle cell. He was followed in the pediatric hematology clinic until he aged out at 18 and transitioned to the adult clinic last year.

Eight months ago, during a construction apprenticeship, he had a vaso-occlusive crisis that reached 8 out of 10 pain. He went to the emergency department at the nearest hospital — not the hospital where his sickle cell clinic is located. He waited four hours at the triage desk. When he finally reached a bed, a nurse told the treating physician within earshot: “young man, says he has sickle cell, the pain is an 8 — we see a lot of this.” He was given oral oxycodone and discharged four hours later with a pain scale of 5. He understood what had been communicated about him in those two words: we see a lot of this.

He has not gone back to an emergency department since. When he has a crisis, he takes two oxycodone from an old prescription, drinks as much water as he can, puts a heating pad on his legs and lower back, and waits. The crises have continued — he has had six in eight months. He estimates that three of them reached 9 out of 10 pain. He is in the sickle cell clinic today for his annual visit. His MRI, done last week, shows two new areas of white matter signal abnormality consistent with silent cerebral infarcts. His transcranial Doppler shows a time-averaged mean of the maximum velocity of 185 cm/second in the middle cerebral artery — borderline elevated, above the 170 cm/s threshold associated with elevated stroke risk.

— ¿Cómo ha ido con las crisis desde que empezó a verlo el año pasado?

How have things gone with the crises since we started seeing you last year?

— Bien. Las he manejado en casa.

Fine. I have been managing them at home.

What the MRI found and why it matters

The clinic nurse, Carlos Mendoza, shows Marcos the MRI report. He does not lead with blame. He leads with what happened in the brain and why it happened, because Marcos needs to understand what six months of home management has cost before he can understand why the plan has to change.

Carlos: — Marcos, el MRI de la semana pasada muestra dos áreas en el cerebro donde los vasos pequeños estuvieron bloqueados en algún momento. Quiero explicarle qué significa esto, porque es importante y no quiero que lo escuche sin entender qué es.

Marcos, the MRI from last week shows two areas in the brain where the small blood vessels were blocked at some point. I want to explain what this means, because it is important and I do not want you to hear it without understanding what it is.

Marcos: — ¿Tuve un derrame?

Did I have a stroke?

Carlos: — Los llamamos infartos cerebrales silenciosos — “silenciosos” porque no producen los síntomas clásicos de un derrame: no hay debilidad súbita, no hay pérdida del habla, no hay visión doble. Pasan sin que la persona sepa que pasaron. Pero el daño sí ocurre. Lo que el MRI está viendo es tejido cerebral que recibió menos sangre de la que necesitaba por el tiempo suficiente como para sufrir daño permanente. En su enfermedad, esto pasa cuando los glóbulos rojos falciformes bloquean los vasos pequeños del cerebro — los mismos vasos que bloquean en cualquier otra parte del cuerpo durante una crisis, pero en el cerebro. El problema es que el cerebro no tiene la misma capacidad que el músculo de recuperarse del daño. El daño que muestra el MRI es permanente.

We call them silent cerebral infarcts — “silent” because they do not produce the classic symptoms of a stroke: no sudden weakness, no loss of speech, no double vision. They happen without the person knowing they happened. But the damage does occur. What the MRI is seeing is brain tissue that received less blood than it needed for long enough to suffer permanent damage. In your disease, this happens when the sickle red blood cells block the small blood vessels of the brain — the same vessels they block anywhere else in the body during a crisis, but in the brain. The problem is that the brain does not have the same capacity as muscle to recover from damage. The damage the MRI shows is permanent.

Marcos is quiet for a moment.

Marcos: — ¿Cuándo pasó?

When did it happen?

Carlos: — No lo sabemos exactamente. El MRI anterior, del año pasado, no mostraba estas áreas. Así que pasó en los últimos doce meses. No puedo decirle cuál crisis fue — puede que haya sido una, puede que haya sido varias. Lo que sé es que las crisis que se manejan con poco medicamento en casa, sin hidratación intravenosa, sin oxígeno si el nivel está bajo, sin el monitoreo que se hace en urgencias — esas crisis duran más y producen más tiempo de hipoxia en los tejidos que las que se tratan rápidamente. Y el cerebro es especialmente sensible a la hipoxia.

We do not know exactly. The previous MRI, from last year, did not show these areas. So it happened in the last twelve months. I cannot tell you which crisis it was — it may have been one, it may have been several. What I know is that crises that are managed with little medication at home, without intravenous hydration, without oxygen if the level is low, without the monitoring done in the emergency department — those crises last longer and produce more time of hypoxia in the tissues than crises that are treated quickly. And the brain is especially sensitive to hypoxia.

Why heat makes sickling worse and what to do instead

Carlos: — Quiero preguntarle sobre lo que hace en casa cuando tiene una crisis. ¿Qué hace?

I want to ask you about what you do at home when you have a crisis. What do you do?

Marcos: — Tomo el oxycodone que me quedó de antes, tomo mucha agua, y pongo una almohadilla de calor en las piernas y en la espalda.

I take the oxycodone I had left from before, I drink a lot of water, and I put a heating pad on my legs and back.

Carlos: — El agua es buena — la hidratación ayuda porque reduce la viscosidad de la sangre. El oxycodone tiene un techo, y el nivel que queda de una prescripción antigua es probablemente insuficiente para una crisis de 9 de 10. Pero lo que quiero explicarle sobre la almohadilla de calor es algo que va a sonar contraintuitivo.

The water is good — hydration helps because it reduces the viscosity of the blood. The oxycodone has a ceiling, and the level left from an old prescription is probably insufficient for a 9 out of 10 crisis. But what I want to explain to you about the heating pad is something that is going to sound counterintuitive.

Marcos: — ¿El calor es malo?

Is heat bad?

Carlos: — El calor local hace que el dolor se sienta mejor. Eso es real. El calor dilata los vasos superficiales, y esa sensación de calor compite con la señal de dolor en el sistema nervioso. Por eso se siente bien. Pero el problema con el calor en la piel durante una crisis de células falciformes es lo que le hace al oxígeno. Cuando la piel está caliente, los glóbulos rojos en los vasos superficiales descargan más oxígeno de lo normal para mantener el metabolismo de los tejidos calientes. Eso significa que los glóbulos rojos que salen de esa área de calor tienen menos oxígeno del que tendrían normalmente. Y menos oxígeno en el glóbulo rojo significa más riesgo de polimerización de la hemoglobina S. En una persona sana, ese efecto no importa mucho. En una persona con HbSS, en la que los glóbulos rojos ya están en el límite de lo que necesitan de oxígeno para no sicklificar, ese efecto puede disparar más sicklificación justo en la crisis.

Local heat makes the pain feel better. That is real. Heat dilates the superficial blood vessels, and that sensation of warmth competes with the pain signal in the nervous system. That is why it feels good. But the problem with heat on the skin during a sickle cell crisis is what it does to oxygen. When the skin is warm, the red blood cells in the superficial vessels discharge more oxygen than normal to maintain the metabolism of the warm tissue. That means the red blood cells leaving that warm area have less oxygen than they would normally. And less oxygen in the red blood cell means more risk of hemoglobin S polymerization. In a healthy person, that effect does not matter much. In a person with HbSS, where the red blood cells are already at the edge of what they need in oxygen not to sickle, that effect can trigger more sickling right in the middle of the crisis.

Marcos: — Entonces la almohadilla me estaba haciendo más daño.

So the heating pad was making things worse.

Carlos: — Potencialmente, sí. Lo que le recomiendo en casa mientras está viniendo a urgencias o esperando que el medicamento oral haga efecto es mantenerse a temperatura neutra — ni frío ni calor. El frío tampoco ayuda: el frío causa vasoconstricción y también puede disparar sicklificación. Neutral. Hidratación, medicamento, y temperatura neutral.

Potentially, yes. What I recommend at home while you are coming to the emergency department or waiting for the oral medication to take effect is to stay at neutral temperature — neither cold nor hot. Cold does not help either: cold causes vasoconstriction and can also trigger sickling. Neutral. Hydration, medication, and neutral temperature.

What to say at triage and when to go

Carlos: — Quiero hablar sobre urgencias, porque lo que me contó sobre la visita de hace ocho meses — esperar cuatro horas en dolor severo y sentir que el personal no le creía — eso no debería haber pasado, y entiendo por qué decidió no volver. Pero quiero que entienda lo que esas ocho visitas de urgencias que no fue le costaron al cerebro.

I want to talk about the emergency department, because what you told me about the visit eight months ago — waiting four hours in severe pain and feeling that the staff did not believe you — that should not have happened, and I understand why you decided not to go back. But I want you to understand what those eight emergency department visits you did not make cost the brain.

A silence.

Carlos: — Lo que voy a darle hoy son dos cosas: una carta de la clínica de células falciformes que describe su diagnóstico, su plan de manejo habitual, y el medicamento que debe recibir en urgencias para una crisis. Muchos hospitales tienen un protocolo específico para crisis de células falciformes que indica que el medicamento debe darse en los primeros treinta minutos. La segunda cosa que quiero que sepa es exactamente qué decir cuando llega a triage.

What I am going to give you today are two things: a letter from the sickle cell clinic that describes your diagnosis, your usual management plan, and the medication you should receive in the emergency department for a crisis. Many hospitals have a specific protocol for sickle cell crises that says the medication must be given within the first thirty minutes. The second thing I want you to know is exactly what to say when you arrive at triage.

Marcos: — ¿Qué digo?

What do I say?

Carlos: — Diga exactamente esto: “Tengo enfermedad de células falciformes, tipo HbSS. Estoy teniendo una crisis vaso-oclusiva. Mi dolor es X de diez.” Y entréguele la carta. Si el hospital tiene un protocolo de células falciformes, esas palabras lo van a activar. Si no lo tiene, la carta le dice al médico lo que necesita saber sobre su plan. Lo que no diga es que el dolor “está fuerte” o que “le duele mucho” sin el diagnóstico por nombre, porque sin el diagnóstico, esa descripción no tiene el mismo sentido clínico para el equipo. Con el diagnóstico, el equipo sabe exactamente qué está pasando y qué hacer.

Say exactly this: “I have sickle cell disease, type HbSS. I am having a vaso-occlusive crisis. My pain is X out of ten.” And hand them the letter. If the hospital has a sickle cell protocol, those words are going to activate it. If it does not, the letter tells the physician what he needs to know about your plan. What you should not say is that the pain “is strong” or that “it hurts a lot” without the diagnosis by name, because without the diagnosis, that description does not carry the same clinical meaning for the team. With the diagnosis, the team knows exactly what is happening and what to do.

Marcos: — Si hubiera sabido que podía decir eso la primera vez, lo hubiera dicho.

If I had known I could say that the first time, I would have said it.

Carlos: — Ahora lo sabe. Y además de la carta, también voy a hablar hoy con usted sobre el tratamiento de transfusión crónica que los resultados del MRI y del Doppler sugieren que necesita, porque eso cambia el manejo de ahora en adelante.

Now you know. And in addition to the letter, I am also going to talk with you today about the chronic transfusion treatment that the MRI and Doppler results suggest you need, because that changes the management from now on.

What chronic transfusion therapy means and why it reduces stroke risk

Carlos: — El Doppler de hoy muestra que la velocidad del flujo en uno de los vasos del cerebro está en un nivel que está asociado con riesgo elevado de derrame en el futuro. Y el MRI muestra que ya hubo daño silencioso. La combinación de esas dos cosas, en alguien de su edad, es exactamente el escenario clínico en el que los estudios han demostrado que la transfusión crónica reduce el riesgo de derrame en aproximadamente noventa por ciento.

Today’s Doppler shows that the flow velocity in one of the brain’s vessels is at a level associated with elevated risk of future stroke. And the MRI shows that there was already silent damage. The combination of those two things, in someone your age, is exactly the clinical scenario in which studies have shown that chronic transfusion reduces the risk of stroke by approximately ninety percent.

Marcos: — ¿Qué significa transfusión crónica?

What does chronic transfusion mean?

Carlos: — Significa que cada tres a cuatro semanas, vendría a recibir una transfusión de glóbulos rojos de un donante. Lo que hace eso es reemplazar una parte de sus glóbulos rojos falciformes con glóbulos rojos normales. Después de cada transfusión, el porcentaje de hemoglobina falciforme en su sangre baja a un nivel donde el riesgo de bloquear los vasos del cerebro es mucho menor. El objetivo es mantener la hemoglobina S por debajo del treinta por ciento de la hemoglobina total. A ese nivel, el riesgo de derrame baja de manera significativa. Las transfusiones que ha recibido antes en crisis agudas son transfusiones de emergencia — esto sería transfusión programada y regular, con el objetivo de mantener ese nivel de protección de manera continua.

It means that every three to four weeks, you would come in to receive a transfusion of red blood cells from a donor. What that does is replace a portion of your sickle red blood cells with normal red blood cells. After each transfusion, the percentage of sickle hemoglobin in your blood drops to a level where the risk of blocking the brain vessels is much lower. The goal is to maintain hemoglobin S below thirty percent of total hemoglobin. At that level, the risk of stroke decreases significantly. The transfusions you have received before in acute crises are emergency transfusions — this would be scheduled and regular transfusion, with the goal of maintaining that level of protection continuously.

Marcos: — ¿Para siempre?

Forever?

Carlos: — Para la mayoría de los pacientes que empiezan el protocolo por riesgo de derrame, sí, la transfusión crónica es un tratamiento a largo plazo. Lo que quiero que sepa es que los pacientes que están en transfusión crónica, bien manejados, tienen tasas de derrame dramáticamente menores que las que tienen los pacientes con el mismo perfil de riesgo que no están en el protocolo. Lo que pasó en los últimos ocho meses — las crisis en casa, los infartos silenciosos — eso sucedió sin el protocolo. El protocolo existe para que no siga sucediendo.

For most patients who start the protocol for stroke risk, yes, chronic transfusion is a long-term treatment. What I want you to know is that patients who are on chronic transfusion, well managed, have dramatically lower stroke rates than patients with the same risk profile who are not on the protocol. What happened in the last eight months — the crises at home, the silent infarcts — that happened without the protocol. The protocol exists so that it does not continue to happen.

Marcos: — Está bien. Dígame qué necesita de mí para empezar.

All right. Tell me what you need from me to start.

Scenario three: Elena and the leg ulcers she has been treating with Neosporin

Elena Fuentes is 34. She has HbSS sickle cell disease, diagnosed in infancy. She works as a daycare aide in Chicago. She has had sickle cell disease all her life but has always described it to people outside her immediate family as “a blood condition” — not because she is ashamed of it, but because explaining sickle cell disease to people who have not heard of it requires more energy than she usually has after a workday.

Three months ago, two areas of skin on her inner ankles began to break down. The right one is now roughly 2 centimeters in diameter. The left one is slightly smaller. Both have irregular edges, a yellowish-gray base that she describes as “wet,” and surrounding skin that is brown and thickened. She has been applying Neosporin every night, covering them with cloth bandages from the drugstore, and waiting for them to close. They have not closed. She is not sure they are any different than they were six weeks ago.

She is in the sickle cell clinic today for a routine visit. She mentions the wounds almost as an afterthought at the end of the visit, as she is gathering her bag to leave.

— Ah, también, tengo dos heridas en los tobillos. Tres meses ya. Las he estado tratando con Neosporina.

Oh, also, I have two wounds on my ankles. Three months already. I have been treating them with Neosporin.

Why sickle cell leg ulcers are not infected wounds

The clinic nurse, Valentina Herrera, asks Elena to show her the wounds. She looks at them carefully. She has seen many sickle cell leg ulcers. These are classic: bilateral medial malleolar, moderate depth, punched-out edges, brown hemosiderin staining in the surrounding skin from chronic venous congestion and repeated red cell breakdown. There is no sign of cellulitis. The wound base does not smell. These are not infected. They are ischemic.

Valentina: — Elena, gracias por mostrarme. Esto es importante. Lo que veo en los tobillos son heridas que son muy características de la enfermedad de células falciformes, y quiero explicarle qué las está causando, porque si entiende el origen, va a entender por qué la Neosporina no las ha cerrado y qué es lo que sí puede cerrarlas.

Elena, thank you for showing me. This is important. What I see on the ankles are wounds that are very characteristic of sickle cell disease, and I want to explain what is causing them, because if you understand the origin, you are going to understand why Neosporin has not closed them and what can actually close them.

Elena: — Una vecina me dijo que las heridas en los tobillos son de la diabetes. Yo no tengo diabetes.

A neighbor told me that wounds on the ankles are from diabetes. I do not have diabetes.

Valentina: — Su vecina tiene razón en que las heridas en los tobillos son comunes en la diabetes — las heridas diabéticas ocurren porque el azúcar elevada daña los nervios y los vasos, y eso hace que la piel sea más vulnerable. Pero hay otro tipo de herida en el tobillo que es completamente diferente en su causa, y ese es el que usted tiene. Las heridas de células falciformes en el tobillo no son por diabetes. Son por isquemia — falta de flujo sanguíneo — causada por los glóbulos rojos falciformes bloqueando los vasos pequeños de la piel en esa área.

Your neighbor is right that wounds on the ankles are common in diabetes — diabetic wounds occur because elevated blood sugar damages the nerves and blood vessels, and that makes the skin more vulnerable. But there is another type of wound on the ankle that is completely different in its cause, and that is the one you have. Sickle cell wounds on the ankle are not from diabetes. They are from ischemia — lack of blood flow — caused by sickle red blood cells blocking the small vessels of the skin in that area.

Elena: — Pero no se ven como si fuera por falta de sangre. Se ven... húmedas.

But they do not look like they are from lack of blood. They look… wet.

Valentina: — Eso es lo confuso de estas heridas. Las heridas isquémicas no se ven siempre como lo que uno espera cuando piensa en “falta de sangre.” La piel en los tobillos — especialmente en el hueso del tobillo interno, donde las dos heridas están — es una piel muy delgada con muy poco tejido graso entre la piel y el hueso. Cuando los glóbulos rojos falciformes bloquean repetidamente los vasos pequeños de esa área, el tejido empieza a morir desde adentro porque no tiene el oxígeno que necesita para sobrevivir. La herida que se forma no se ve como un moretón o como una quemadura. Se ve como una pérdida de tejido. El centro se abre, los bordes se elevan un poco, y lo que queda en el fondo es tejido que no puede sanar porque el suministro de sangre que necesita para sanar está reducido.

That is what is confusing about these wounds. Ischemic wounds do not always look like what one expects when thinking about “lack of blood.” The skin on the ankles — especially on the inner ankle bone, where both wounds are — is very thin skin with very little fatty tissue between the skin and the bone. When sickle red blood cells repeatedly block the small vessels of that area, the tissue starts to die from the inside because it does not have the oxygen it needs to survive. The wound that forms does not look like a bruise or a burn. It looks like a loss of tissue. The center opens up, the edges are slightly raised, and what remains at the base is tissue that cannot heal because the blood supply it needs to heal is reduced.

Elena: — ¿Entonces no es una infección.

So it is not an infection.

Valentina: — El problema principal no es una infección. Puede haber bacterias en la superficie de la herida — cualquier herida abierta acumula bacterias — pero esas bacterias no son la razón por la que la herida no cierra. La razón es que el tejido que rodea la herida no tiene el flujo sanguíneo suficiente para fabricar el colágeno nuevo, los vasos nuevos, y las células nuevas que necesita para cicatrizar. La Neosporin reduce las bacterias de la superficie. Eso no es malo. Pero no llega al problema de fondo.

The main problem is not an infection. There may be bacteria on the wound surface — any open wound accumulates bacteria — but those bacteria are not the reason the wound is not closing. The reason is that the tissue around the wound does not have enough blood flow to manufacture the new collagen, new blood vessels, and new cells it needs to heal. Neosporin reduces the bacteria at the surface. That is not bad. But it does not reach the underlying problem.

What wound care clinic does and how long healing takes

Elena: — ¿Entonces qué cierra estas heridas?

So what closes these wounds?

Valentina: — La clínica de cuidado de heridas tiene varios elementos que trabajan juntos. El primero es el desbridamiento — que es remover el tejido que está muerto o que no tiene posibilidad de sanar. Ese tejido muerto en el fondo de la herida bloquea el tejido nuevo. El segundo elemento son apósitos especializados — no las vendas de tela de la farmacia, sino materiales que mantienen la herida en el nivel exacto de humedad que le permite a las células nuevas migrar hacia adentro sin que la herida se seque ni que tenga demasiada humedad. El tercero, en algunas heridas de células falciformes, es comprensión si hay insuficiencia venosa asociada, que es común en el tobillo. Y el cuarto — y esto es lo más importante — es que si podemos optimizar el manejo de su enfermedad de células falciformes mientras la herida está sanando, eso reduce la frecuencia con la que los glóbulos rojos bloquean los vasos de esa área y le da al tejido más oportunidad de recibir el flujo que necesita para cerrar. Eso puede significar ajustar la hidroxiurea, o en algunos casos una transfusión.

The wound care clinic has several elements that work together. The first is debridement — which is removing tissue that is dead or that has no possibility of healing. That dead tissue at the base of the wound blocks new tissue. The second element is specialized dressings — not the cloth bandages from the drugstore, but materials that maintain the wound at the exact level of moisture that allows new cells to migrate inward without the wound drying out or having too much moisture. The third, in some sickle cell wounds, is compression if there is associated venous insufficiency, which is common in the ankle. And the fourth — and this is the most important — is that if we can optimize the management of your sickle cell disease while the wound is healing, that reduces the frequency with which the red blood cells block the vessels in that area and gives the tissue more opportunity to receive the flow it needs to close. That may mean adjusting the hydroxyurea, or in some cases a transfusion.

Elena: — ¿Cuánto tiempo tarda en cerrar?

How long does it take to close?

Valentina: — Quiero ser honesta con usted sobre esto, porque es importante. Las heridas de células falciformes en el tobillo son las heridas más lentas en sanar de las que vemos en esta clínica. Con cuidado especializado y buen control de la enfermedad de base, pueden tardar de tres a doce meses en cerrar. Algunas tardan más. Tres meses de Neosporin no han cerrado estas heridas, y eso no quiere decir que usted hizo algo mal — quiere decir que el tratamiento que tiene disponible en su casa no llega al problema. El cuidado de heridas es un proceso lento. Pero “lento con el tratamiento correcto” es completamente diferente de “no cerrar sin el tratamiento correcto.”

I want to be honest with you about this, because it is important. Sickle cell wounds on the ankle are the slowest-healing wounds we see in this clinic. With specialized care and good control of the underlying disease, they can take three to twelve months to close. Some take longer. Three months of Neosporin have not closed these wounds, and that does not mean you did something wrong — it means that the treatment you have available at home does not reach the problem. Wound care is a slow process. But “slow with the right treatment” is completely different from “not closing without the right treatment.”

Elena: — No quiero perder el trabajo por ir a la clínica de heridas.

I do not want to lose work going to the wound care clinic.

Valentina: — Lo entiendo. Voy a pedir un turno que sea antes de las ocho de la mañana o después de las cuatro de la tarde, si está disponible. Y quiero que sepa que si estas heridas no se tratan, el riesgo es que en seis meses sean más grandes, no más pequeñas. Las heridas de células falciformes que no reciben tratamiento especializado no suelen resolverse solas — tienden a crecer. El trabajo que se pierde en citas de heridas es mucho menos que el trabajo que se pierde en una hospitalización si la herida se complica.

I understand. I am going to request an appointment that is before eight in the morning or after four in the afternoon, if it is available. And I want you to know that if these wounds are not treated, the risk is that in six months they will be larger, not smaller. Sickle cell wounds that do not receive specialized treatment do not usually resolve on their own — they tend to grow. The work lost to wound care appointments is much less than the work lost to a hospitalization if the wound becomes complicated.

Elena: — Entonces no es infección. Es lo mismo que me pasa adentro, pero en la piel.

So it is not infection. It is the same thing that happens to me inside, but in the skin.

Valentina: — Exactamente. La misma hemoglobina falciforme, los mismos vasos pequeños bloqueados, el mismo tejido sin el oxígeno que necesita. Solo que en la piel se puede ver.

Exactly. The same sickle hemoglobin, the same blocked small vessels, the same tissue without the oxygen it needs. Just that in the skin you can see it.

Eight practical phrases for sickle cell disease clinic nurses

These phrases address the three communication failures most likely to produce harm in Spanish-speaking patients with sickle cell disease: the patient who stopped a life-altering medication because of misinformation; the patient who is managing crises at home and accumulating end-organ damage; and the patient whose sickle cell complications have been framed as something else entirely.

“La hidroxiurea en su enfermedad trabaja haciendo que el cuerpo produzca hemoglobina fetal, que se mezcla con la hemoglobina falciforme y reduce la proporción de glóbulos que se pueden deformar — no es el mismo uso que en el cáncer, y no es la misma dosis.” (Hydroxyurea in your disease works by making the body produce fetal hemoglobin, which mixes with the sickle hemoglobin and reduces the proportion of cells that can deform — it is not the same use as in cancer, and it is not the same dose.)
“Lo que le dijo su amiga fue verdad para ella. Lo que le estoy diciendo es verdad para usted. Son el mismo medicamento usado de maneras diferentes.” (What your friend told you was true for her. What I am telling you is true for you. They are the same medication used in different ways.)
“Cuando el dolor llega a seis de diez y los medicamentos de la casa no lo controlan en dos horas, ese es el momento de ir a urgencias — no después de cuatro horas en cama.” (When the pain reaches six out of ten and the home medications do not control it within two hours, that is the moment to go to the emergency department — not after four hours in bed.)
“En urgencias, diga: tengo enfermedad de células falciformes, tipo HbSS, estoy teniendo una crisis vaso-oclusiva, y pida si tienen un protocolo para esto — esas palabras activan el protocolo si el hospital lo tiene.” (In the emergency department, say: I have sickle cell disease, type HbSS, I am having a vaso-occlusive crisis, and ask if they have a protocol for this — those words activate the protocol if the hospital has one.)
“El calor en la piel durante una crisis hace que los glóbulos rojos de esa área descarguen más oxígeno, lo que puede disparar más sicklificación — temperatura neutral es lo mejor mientras el medicamento hace efecto.” (Heat on the skin during a crisis causes the red blood cells in that area to discharge more oxygen, which can trigger more sickling — neutral temperature is best while the medication takes effect.)
“El infarto silencioso no produce los síntomas clásicos de un derrame, pero el daño es permanente — por eso el MRI lo encontró sin que usted lo hubiera sentido en el momento.” (The silent infarct does not produce the classic symptoms of a stroke, but the damage is permanent — that is why the MRI found it without you having felt it at the time.)
“La transfusión crónica reemplaza sus glóbulos rojos falciformes con glóbulos de un donante cada tres o cuatro semanas, manteniendo la hemoglobina S por debajo del treinta por ciento — a ese nivel, el riesgo de derrame baja en noventa por ciento.” (Chronic transfusion replaces your sickle red blood cells with donor red blood cells every three to four weeks, keeping hemoglobin S below thirty percent — at that level, the risk of stroke decreases by ninety percent.)
“Estas heridas en el tobillo son isquémicas, no infecciosas — la Neosporina trata la superficie, pero el problema es la falta de flujo sanguíneo en el tejido; el cuidado especializado de heridas puede tardar meses, pero es el único camino para cerrarlas.” (These ankle wounds are ischemic, not infectious — Neosporin treats the surface, but the problem is the lack of blood flow in the tissue; specialized wound care may take months, but it is the only path to closing them.)

What each conversation required from the clinic nurse

Alejandra did not begin with a correction. She began with a validation: your friend was telling the truth about her own experience. That validation is what made the explanation credible. If the nurse had opened with “that is not true about hydroxyurea,” Daniela would have had to choose between the clinical authority of a nurse and the lived authority of a friend. By starting with “what your friend said was true for her,” the nurse acknowledged the legitimacy of the information while creating space to explain why it applied differently in Daniela’s case. The explanation that followed — fetal hemoglobin, dilution of HbS, suppression of polymerization — was received by a patient who no longer needed to defend her source, because her source had already been defended.

Carlos did not begin with the MRI. He began with the event: the four-hour wait, the comment he overheard, the decision not to go back. He named the harm — “that should not have happened” — before he named the consequence. That ordering matters. A patient who believes that the emergency department does not believe him needs to hear that his experience was real and wrong before he can hear a plan that depends on him going back there. The phrase he left with — “tengo enfermedad de células falciformes, tipo HbSS, estoy teniendo una crisis vaso-oclusiva” — is a tool the clinic nurse gave him so that the next ED encounter has a different opening.

Valentina did not dismiss the neighbor’s explanation. She confirmed the part that was true — that diabetic wounds on the ankle are common and important — and then distinguished the mechanism that applied to Elena’s situation. The phrase Elena arrived at on her own — “es lo mismo que me pasa adentro, pero en la piel” — is exactly the analogy the clinic nurse was building toward. A patient who constructs the analogy herself understands it in a way that a patient who receives it already assembled does not. The nurse’s job was to lay the components; the patient’s job was to connect them.

The population this post is for

Sickle cell disease in the United States disproportionately affects Black Americans, but approximately ten percent of people with sickle cell disease in the United States have Hispanic or Latino ancestry, with the highest prevalences in communities from the Caribbean, Central America, and South America. In Florida, California, Texas, New York, and Illinois — the five states with the largest Latino populations — sickle cell disease clinic nurses regularly encounter patients whose primary language is Spanish and whose understanding of their disease has been shaped by the limited clinical vocabulary available to them in that language.

The scenarios in this post are drawn from the three clinical failure modes that appear most frequently at the intersection of sickle cell disease and health literacy in Spanish: the informed but incorrect discontinuation (the patient who stopped the right medication for a logical reason), the avoidant adherence (the patient who is following the plan for everything except the one encounter that matters most), and the unconnected complication (the patient whose sickle cell complication has been attributed to something else because no one explained the connection in terms she could use).

In each case, the nurse’s clinical Spanish does not need to be perfect. It needs to be specific enough that the patient understands the mechanism, specific enough that the patient can articulate what she was told to someone who asks her about it later, and specific enough that the patient recognizes the failure for what it was — a gap in what she knew — rather than a personal error requiring defense.

Practice these conversations at ClinicaLingo

ClinicaLingo offers AI-voiced clinical scenarios for working nurses, EMTs, PAs, and front-desk staff. The practice section covers the encounters you are most likely to have tomorrow — hematology clinic conversations, medication adherence discussions, ED navigation, and wound care explanations in clinical Spanish. The free 50-phrase PDF includes the foundational vocabulary for sickle cell disease encounters. See also Spanish for hematology clinic nurses, Spanish for infusion nurses, chronic disease management in Spanish, Spanish for wound care nurses, and the full clinical Spanish blog.

ClinicaLingo is a clinical Spanish learning tool for working clinicians. Content is written for educational purposes and does not constitute medical advice. Clinical protocols, dosing, and management decisions should follow your institution’s guidelines and the judgment of the treating physician.